Febrile episodes in liver transplant recipients were prospectively evaluated. Fever was due to infections in 78% of the episodes (35 of 45) and due to noninfectious causes in 22% (10 of 45). The predominant sources of fever were bacterial infections (62%; 28 of 45) and viral infections (6%; 7 of 45), whereas rejection accounted for only 4% of the episodes (2 of 45). Forty percent of the infections were unaccompanied by fever; fungal infections were significantly less likely to be associated with fever than were viral or bacterial infections (P Å .001). Eighty-six percent (6) of the 7 febrile viral infections were due to viruses other than cytomegalovirus, of which human herpesvirus-6 was the predominant pathogen (71%; 5 of 7). Eighty percent (four) of the five febrile episodes with leukopenia were due to human herpesvirus-6. Episodes of fever were most likely to occur within 12 weeks (58%) or 1 year (29%) after transplantation; 100% of the latter episodes were in patients with recurrent hepatitis due to hepatitis C virus, malignancy, or chronic hemodialysis. In conclusion, cytomegalovirus and rejection were no longer the predominant etiologies of fever in liver transplant recipients, and viruses other than cytomegalovirus (e.g., human herpesvirus-6) are emerging as a significant cause of febrile viral illnesses in these patients.
Fever is a common clinical event in organ transplant recipients receiving tacrolimus as a primary immunosuppressive agent. We also offer recommendations regarding the approach ents. Although fever is frequently suspected and proven to be a harbinger of infections, diverse etiologies -including a toward and evaluation of febrile illnesses in liver transplant recipients. number of noninfectious complications -may account for fever in transplant recipients. Nevertheless, its occurrence in the posttransplantation setting is worrisome and always regarded Methods with concern.
Over a 2-year period, consecutive liver transplant recipients In recent years, significant advances have taken place in developing fever or infections at the newly established liver the field of liver transplantation. The new immunosupprestransplantation service at the Pittsburgh Veterans Affairs Medisive agent tacrolimus has gained widespread use; immunocal Center were prospectively followed. suppressive therapy has become more conservative; surgical
Immunosuppression. All patients received tacrolimus and techniques have been refined; rapid and reliable diagnostic low-dose prednisone as immunosuppressive agents. Rejection tools for infectious agents, particularly viruses, have been episodes were treated with 1 g of methylprednisolone bolus, introduced; and prophylaxis for opportunistic pathogens, with or without steroid recycles (methylprednisolone was given e.g., cytomegalovirus (CMV) and Pneumocystis carinii, has intravenously in four divided doses daily; the dose was tapered proven highly efficacious [1 -3] .
from 200 mg to 20 mg per day over 6 days). OKT3 was It has been proposed that the above factors have led to an reserved for steroid-resistant rejection; however, none of the overall decrease in the incidence of infections [1] and perhaps patients in this study received OKT3. to the evolving spectrum of infectious morbidity. However, the Antimicrobial prophylaxis. Perioperative prophylaxis conimpact of these variables on the incidence, causes, and outcome sisted of administration of ampicillin and cefotaxime for 24 of fever remains unknown. In fact, despite voluminous literahours. Patients allergic to penicillin received clindamycin and ture on infections in liver transplantation, no study to our aztreonam. Transplant recipients who were not allergic to sulknowledge has systematically analyzed fever in liver transplant fonamides received 80 mg of trimethoprim and 400 mg of recipients.
sulfamethoxazole daily indefinitely, as prophylaxis for P. cariThe objectives of this study, therefore, were to assess the nii. Aerosolized pentamidine was given instead to patients who incidence and etiology of fever (with special reference to the were allergic to trimethoprim-sulfamethoxazole. timing of onset post-transplantation) in liver transplant recipiAll patients received acyclovir (200 mg orally t.i.d.) for 1 month as prophylaxis for herpes simplex virus. Surveillance cultures for CMV (buffy coat) were performed every 2 weeks for 2 months and then monthly for 4 months. Preemptive short-occasions during a 24-hour period [5] . We selected a cutoff of reactivity with other herpesviruses, e.g., CMV and EpsteinBarr virus, has previously been explicitly demonstrated [10] . 37.5ЊC rather than 38ЊC since the latter definition would have essentially excluded low-grade temperatures, which are a freParvovirus B19 infection was diagnosed by the detection of this virus in the blood with PCR assay and by the demonstration quent occurrence in the transplant setting and are equally worrisome as temperatures of a higher degree. Hypothermia was of histopathologic changes in the bone marrow diagnostic of parvovirus B19 infection [11] . defined as a temperature of õ96ЊF.
A uniform diagnostic protocol was employed for the evaluaFever was considered postprocedural if there was a transient temperature elevation during a 48-hour period following an tion of febrile patients. APACHE II scores were determined in the first 24 hours of the study patients' illness. All febrile invasive diagnostic procedure and no evidence of infection elsewhere [12] . Fever was considered to be due to rejection if patients underwent a thorough physical assessment. Determination of complete blood cell count; liver and renal function tests; the patient had clinical or biopsy-proven rejection, completely responded to antirejection therapy, and had no other identifiable blood and urine cultures; chest roentgenography; and buffy coat surveillance cultures for CMV antigenemia were performed for source of fever or infection. A febrile episode was defined as resolved after 5 days of normal temperature, as previously all patients. Sputum cultures (bacterial, Legionella, fungal, and mycobacterial) and urinary Legionella antigen testing were perdefined [12] . For the purpose of this study, all febrile episodes were considered individually, as if in separate patients [5] . All formed for patients with suspected or radiographically evident pneumonia. Cultures for human herpesvirus-6 (HHV-6) in the febrile or infected patients were followed on a daily basis by an infectious disease physician (NS). blood samples were performed for patients with fever of undetermined source and/or leukopenia. Other diagnostic tests such Statistical analysis. Patient demographics (e.g., age and sex) and laboratory data were entered into PROPHET Statistics as serum cryptococcal antigen assays, imaging studies (e.g., CT scans), or invasive procedures (e.g., paracentesis, lumbar (BBN Systems and Technologies, Cambridge, MA). Contingency data were compared with the x 2 or Fisher's exact test. puncture, bone marrow or liver biopsy, and bronchoscopy) were performed as clinically indicated.
Continuous variables were compared with the ANOVA and Kruskal-Wallis tests. Infections were defined with use of criteria proposed by the Centers for Disease Control and Prevention and as previously reported with regard to liver transplant recipients [6, 7] . Invasive fungal infections were diagnosed by either a positive blood Results culture (e.g., for Candida and Cryptococcus) or evidence of tissue invasion (e.g., aspergillosis) on biopsy or autopsy. PneuSeventy consecutive episodes of fever or documented infections occurred during the study period in 43 liver transplant monia was considered to be present when a new pulmonary infiltrate developed in conjunction with both clinical symptoms recipients. Eighty-four percent (36) of the 43 patients underwent transplantation during the study period, whereas 16% (7) (fever, cough, or hypoxia) and isolation of bacteria in pleural fluid or blood cultures or isolation in heavy growth in pure had undergone transplantation a median of 36 months (range, 4.7 -74 months) before the initiation of the study. culture of respiratory secretions [7] . Peritonitis was defined by isolation of a pathogen and/or an ascitic fluid polymorphonuOf the 36 patients who received transplants during the study, 36% (13) never experienced fever or infection, 6% (2) had an clear cell count of ú250/mm 3 in a percutaneous aspirate or an intraoperative specimen. Wound infection was defined as infection but no fever, and 58% (21) had at least 1 febrile episode (12 patients had only 1 febrile episode, 6 patients had erythema and purulent drainage from the wound that required debridement with or without antibiotic therapy.
2, 2 patients had 3, and 1 patient had 4). Of the 7 patients who underwent transplantation before the study, 4 had a single CMV infection and disease were defined as previously reported [4] . HHV-6 viremia was detected by isolation in cell episode, 2 had 2 episodes, and 1 had 4 episodes of fever during the study period. culture or the shell vial culture assay, as previously reported [8, 9] . For the shell vial assay, peripheral blood mononuclear All patients were male, and the median age was 46 years (range, 25 -70 years). The underlying liver disease was viral cells were inoculated on human diploid fibroblasts for 48 hours and stained with antiserum specific for the major immediate hepatitis in 44%; 81% of the patients with viral hepatitis were infected with hepatitis C virus, 13% with hepatitis B virus, and early antigen of HHV-6. In bone marrow and liver transplant recipients, a sensitivity of 86% and a specificity of 100% have 6% with both hepatitis B and C viruses. Thirty-nine percent of the patients had end-stage liver disease due to alcoholism, been reported with this assay [8] . Immunohistochemical staining specific for HHV-6 was used to detect HHV-6 in the tissues and 22% had other liver diseases (autoimmune liver disease, total parenteral nutrition -associated liver disease, cryptogenic [9, 10] . This procedure employs immunohistochemical staining with murine monoclonal antibody reactive against the structural cirrhosis, and primary sclerosing cholangitis). Etiology of fever. There were 45 episodes of fever and 25 protein 101 of HHV-6 variant A and structural protein gp 82 of HHV-6 variant B, and it detects productively infected cells episodes of documented infections (without fever) in the study patients. Fever was due to infections in 78% (35) and noninfecbut not latent HHV-6 in the tissues [10] . Lack of cross-/ 9c43$$ja29
11-24-97 21:24:17 cida UC: CID Table 2 . Types and sources of infections, stratified by association tious causes in 22% (10) of the 45 febrile episodes (table 1) .
with fever, in liver transplant recipients.
Eighty percent (28) of the 35 febrile infections were due to bacteria, 20% (7) to viruses, and none to fungi.
No. of episodes
Of the 60 documented infections, 72% (43) were bacterial, 17% (10) were viral, and 12% (7) None of the fungal infections were accompanied by fever.
Mycobacterium tuberculosis 1 0
Of the 7 episodes of fungal infections, 2 were due to invasive were biopsy-proven), and 3 were due to fungemia caused by
Candida albicans (secondary to urinary tract infection in 2 Viral (n Å 10), due to: 7 3 patients and catheter-related in 1). NOTE. None of the variables except the incidence of rigors (P Å .047) differed significantly between the three groups.
* Serum creatinine level of ú2.0 mg/dL. † The values reported are for febrile patients only, since infections without fever by definition would not be accompanied by fever. T max refers to maximum temperature during the febrile illness.
fever, noninfectious fever, or infection without fever are out-13% (6) between 4 and 12 weeks, 13% (6) between 12 weeks and 1 year, and 29% (13) after 1 year post-transplantation. lined in table 3 .
Timing of onset of fever after transplantation. Overall, Fifty percent (3) of the 6 febrile episodes occurring within 2 weeks of transplantation were due to bacterial infections, 33% 58% (26) of the 45 febrile episodes occurred within 12 weeks of transplantation (table 4), 13% (6) occurred within 2 weeks, (2) were due to rejection, and 17% (1) was due to transient / 9c43$$ja29 11-24-97 21:24:17 cida UC: CID postoperative fever of unknown etiology that resolved sponta-3 days of the evaluation process, whereas in 27% (12) the source of fever was not apparent at 3 days. neously.
Between 2 and 4 weeks post-transplantation, 50% (3) of the Infections accounted for 58% (7) of the 12 fevers for which a diagnosis could not be established in 3 days of appropriate 6 febrile episodes were due to viral infections with HHV-6 and the other 3 febrile episodes were due to methicillin-resistant investigations; these included 5 cases of HHV-6 infection, 1 of varicella zoster virus infection (with atypical-appearing skin Staphylococcus aureus bacteremia, vancomycin-resistant Enterococcus faecium peritonitis, and Citrobacter freundii pneulesions), and 1 of pneumonia due to Serratia marcescens (where an infiltrate was not apparent radiographically at the monia, respectively. Between 4 and 12 weeks post-transplantation, 50% (7) of the 14 febrile episodes were due to bacterial outset). Twenty-five percent (3) of the 12 cases of fever of unknown origin at 3 days were due to noninfectious causes infections (pneumonia, 3; bacteremia, 3; cholangitis, 1), 21% (3) to viral infections (HHV-6, 1; CMV, 1; varicella zoster (malignancy, 1; drug-induced fever, 1; and adrenal insufficiency, 1). In 5% (two) of the 45 patients, the etiology of fever virus, 1), 14% (2) to noninfectious causes (postprocedural, 1; transfusion reaction, 1), and 7% (1) to an unknown etiology.
was not identified; one of these patients had transient fever in the early posttransplantation period that resolved spontaneNearly one-third (13) of the 45 febrile episodes occurred after 1 year post-transplantation, and 100% of these were in ously, while the etiology of fever in the other patient was not determined. patients who had recurrent hepatitis due to hepatitis C virus, were undergoing chronic hemodialysis, or had a malignancy.
Community vs. nosocomially acquired fever. Eighty-two percent (37) of the 45 febrile episodes were nosocomial, and Leukocytosis. Leukocytosis was observed in 27% (12) of the 45 febrile patients, including 29% (10) of the 35 patients 18% (8) were due to community-acquired pathogens. Of the 37 febrile episodes that were nosocomial, 76% (28) were infecwith infections (all bacterial) and 20% (2) of the 10 patients with fever of noninfectious etiology (rejection, 1; adrenal insuftious fever and 24% (9) were noninfectioins. Sixty-two percent (23) of the 37 nosocomial febrile episodes were due to bacteria, ficiency, 1). Leukocytosis also occurred in 52% (12) of the 23 infections without fever. Eighty percent (8) of the 10 patients and 13% (5) were due to viruses. Likewise, 63% (5) of the 8 febrile episodes caused by community-acquired pathogens with noninfectious fever and 54% (19) of the 35 patients with fever due to infections (bacterial, 17; viral, 2) had normal WBC were due to bacteria, and 25% (2) were due to viruses. Mortality. At 30 days, 19% (13) of the 70 episodes of fever counts during the febrile episodes.
Leukopenia. Eight patients had leukopenia (WBCs, or infections were associated with death. Among patients with fever, 10% of the noninfectious vs. 14% of the infectious febrile õ3,000/mm 3 ). The etiology of leukopenia was HHV-6 in 4 patients, chemotherapy for malignancy in 2, drug-induced episodes were associated with death. Mortality was 100% (2 of 2) among the hypothermic patients, 22% (5 of 23) among in 1, and unknown in 1. Five of these 8 patients had infections with fever (HHV-6 infection in 4 and Klebsiella pneunormothermic patients, and 14% (6 of 43) among febrile patients. Mortality was zero among patients with viral infection, moniae bacteremia of biliary source in 1), and 3 had infections without fever (Clostridium difficile colitis in 2 and 24% among patients with bacterial infection, and 29% among patients with fungal infection. Of the 13 patients who underbacterial pneumonia in 1). Eighty percent (four) of the five patients infected with HHV-6 in this study had leukopenia went transplantation during the study period but developed neither fever nor infection, none died. with a WBC count ranging from 700/mm 3 to 1,800/mm 3 . HHV-6 was detected in 80% (4) of the 5 patients with leukopenia of undetermined etiology, vs. 0 of the 3 patients with leukopenia of defined etiology. Discussion Noninfectious etiologies. In 18% (eight) of the 45 febrile episodes, a noninfectious cause was considered to be the etiol-A prospective study of fever in liver transplant recipients has never been conducted. Indeed, to our knowledge, no study ogy of fever. These causes included malignancy in 2 patients (hepatocellular carcinoma in 1 and carcinomatous meningitis in the 1990s has assessed fever in any solid-organ-transplant recipients. Given the multiplicity of possible etiologies, dedue to posttransplantation lymphoproliferative disorder in 1), interferon therapy in 1, platelet transfusion reaction in 1, posttermining the cause of posttransplantation fever can be challenging and often difficult. Delineation of the likely sources procedural fever (following T-tube cholangiography) in 1, and adrenal insufficiency in 1.
and characteristics of the febrile illness, particularly in the context of timing of onset after transplantation, can assist sigFever of unknown etiology. We assessed the febrile episodes (both infectious and noninfectious) in which the source nificantly in the evaluation process.
In a study of fever in renal transplant recipients by Peterson of fever could not be ascertained in 3 days of appropriate investigations [13] . A 3-day cutoff was chosen since most diaget al. in 1981, infections were found to be the source in nearly 75% of the febrile episodes [14] . Viral infections (almost exclunostic tests, including routine microbiological cultures, can be completed within that time period [13] . In 73% (33) of the 45 sively due to CMV) were responsible for ú50% of all febrile episodes [14] . Rejection accounted for 13% of the episodes of febrile patients, the etiology of the fever was determined within / 9c43$$ja29
11-24-97 21:24:17 cida UC: CID fever and was as common as bacterial infection as a cause of ents [14, 18] . It has been proposed, however, that rejection episodes in the modern immunosuppressive era have become fever [14] .
The spectrum of etiologic agents of fever in organ transplant less florid and therefore less likely to be associated with signs of acute inflammation, including fever [18] . Indeed, 83% of recipients may indeed be evolving. Our study of liver transplant recipients showed that although infections still accounted for the acute rejection episodes in renal transplant recipients in 1994 were not associated with fever [18] . In our study, only 77% of the episodes of fever, viral infections were responsible for only 22% of the episodes and CMV accounted for only 7% 4% of the febrile episodes were due to rejection. Timing of onset of fever after transplantation can be a valuof all febrile illnesses. A number of factors, including use of tacrolimus as the primary immunosuppressive agent [15] , able tool in ascertaining the etiology of fever [19] . Febrile episodes were most likely to occur within 12 weeks (58%) or infrequent use of OKT3, routine employment of preemptive CMV prophylaxis, and a low number (9%) of patients with after 1 year posttransplantation (29%). Fever in the very early posttransplantation period (within 2 weeks) was due to either CMV mismatches (recipient-negative, donor-positive CMV serological status), may have accounted for the low incidence of catheter-related bacteremia or rejection. One-half of the febrile episodes between 2 and 4 weeks posttransplantation were due CMV disease in our patients. Sixty-two percent of the febrile episodes were due to bacterial infections, whereas only 4% to HHV-6, and the other half were due to bacterial infections. Patients with recurrent HCV hepatitis were identified as a were due to rejection.
We have shown that viruses other than CMV are emerging as unique subgroup of patients in whom morbidity due to lateonset infections was evident [20] . A vast majority of the paa predominant cause of viral infections and fever in transplant recipients. Seventy percent (7) of all 10 viral infections and tients with fever after 1 year had recurrent, persistent, or newonset comorbid illness after transplantation (e.g., recurrent 86% (6) of 7 febrile viral infections were due to viruses other than CMV, of which HHV-6 was the predominant pathogen.
HCV hepatitis, posttransplantation malignancy, or requirement of hemodialysis). Although fever in these patients was predomAlthough well recognized as a significant cause of marrow suppression and interstitial pneumonitis in bone marrow transinantly due to bacterial infections (bacteremia or pneumonia), late-onset CMV disease and invasive fungal infections were plant recipients [9, 16, 17] , HHV-6 may also be an important pathogen in organ transplant recipients. Eighty percent (four) also documented in these patients. In our study, 17% of the febrile episodes occurring ú2 of the five febrile episodes with leukopenia in our study were due to HHV-6. Furthermore, HHV-6 was more likely to be years after transplantation were due to malignancy. Adrenal insufficiency was observed in 10% (one) of our 10 patients isolated in the blood cultures of patients with idiopathic marrow suppression than in those of patients with marrow suppression with noninfectious fever. Clinical settings in which this potentially life-threatening but treatable complication should be susof defined or known etiology in our study. Although our numbers were small, these data nevertheless suggest that HHV- 6 pected have previously been reported [21] . A significant cause of noninfectious fever in transplant recipients has been OKT3-should be sought in patients with fever and leukopenia of unclear etiology after liver transplantation.
induced or antilymphocyte antibody -induced fever; 23% of the 47 febrile episodes in a study of renal transplant recipients It is a well-recognized fact that iatrogenic immunosuppressive agents may blunt the febrile response and that immunosupreceiving cyclosporine were due to antilymphocyte therapy [18] . Use of tacrolimus has been associated with a lower repressed patients, including transplant recipients with infections, may not become febrile. However, the frequency, types, and quirement for adjunctive immunosuppression [22] . Indeed, none of our patients received OKT3. Thus, OKT3 antibodyoutcome of infections with or without associated fever in liver transplant recipients have not previously been reported. It is induced fever may be a less relevant cause of fever in the modern immunosuppressive era because of the infrequent use noteworthy that 40% of the patients with documented infections in our study did not have fever. Fungal infections were signifiof these agents. Etiology of fever in transplant recipients can often be obcantly less likely to be associated with fever than were viral or bacterial infections. Bacterial infections were more likely to scure at the outset. Our data show that in nearly three-fourths of the febrile patients a source of fever can be ascertained be accompanied by fever if they were associated with bacteremia (80%) as compared with bacterial infections without bacwithin 3 days of evaluation by a careful physical examination, appropriate imaging studies, and routine laboratory tests and teremia (52%; P Å .056). In the absence of bacteremia, 40% (12) of the 30 bacterial infections were unaccompanied by cultures (outlined in the Methods section). Infections accounted for a significant proportion of the fevers in liver fever. The mortality rate, however, did not differ significantly between patients with infections who did or did not develop transplant recipients of which the etiology could not be determined within 3 days of evaluation; 42% of such febrile fever.
Rejection has been considered a significant cause of fevers of episodes were due to viral infections (predominantly with HHV-6). Noninfectious etiologies (malignancy, adrenal insufnoninfectious etiology in organ transplant recipients. Rejection accounted for 50% of the noninfectious febrile episodes and ficiency, and drug fever) accounted for one-fourth of the febrile episodes of unclear etiology. 13% -32% of all fevers in two studies of renal transplant recipi-/ 9c43$$ja29
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